1) |
Crofford LJ, Rowbotham MC, Mease PJ, et al : Pregabalin 1008-105 Study Group. Pregabalin for the treatement of fibromyalgia syndrome: results of a randomized, double-blind, -controlled trial. Arthritis Rheum 2005 ; 5 : 1264-1273. |
2) |
Arnold LM, Goldberg DL, Stanford SB, et al : Gabapentin in the treatment of fibromyalgia : a randomized double-blind, placebo-controlled, multicenter trial. Arthritis Rheum 2007 ; 56 : 1336-1344. |
3) |
Usui C, Hatta K, Doi N, et al : Brain perfusion in fibromyalgia patients and its differences. between responders and poor responders to gabapentin. Arthritis Research & Therapy 2010 ; 12 : R64. |
4) |
臼井千恵,荒谷聡子,八木下尚子,他 : 線維筋痛症のSPECT所見およびガバペンチンの有効性の予測について. 第2回日本線維筋痛症学会抄録集. 2010 ; p74. |
5) |
Mease PJ, Clauw DJ, Gendreau RM, et al : The efficacy and safety of mulnacipran for treatment of fibromyalgia, a randomized, double-blind, placebo-controlled trial. J Rhematol 2009 ; 36 : 398-409. |
6) |
Arnold LM, Rosen A, Prittchett YL, et al : A randomized, double-blind, placebo- controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005 ; 119 : 5-15. |
7) |
岡 寛,西岡久寿樹 : 抗痙攣薬の適応と有効性. 第2回日本線維筋痛症学会抄録集. 2010 ; p46. |
8) |
西岡久寿樹 :「線維筋痛症診療ガイドライン2009」から見る線維筋痛症診療の現状. 日本医事新報 2010 ; 4505 : 54-58. |
9) |
Frederick Wolfe, et al : The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care & Research 2010 ; 62 (5) : 600-610. |
10) |
Usui C, Hatta K, Aratani S, et al : Japanese version of the 2010 American College of Rheumatology preliminary diagnostic criteria for fibromyalgia symptom scale. Modern Rheum, in press. |
11) |
長田賢一,富永桂一朗,岡 寛,他 : 日本語版Fibromyalgia Impact Questionnairer(JFIQ)の開発 : 言語的妥当性を担保とした翻訳版の作成.臨床リウマチ 2008 ; 20 : 19-28. |
西岡久寿樹
|